SCHEMBL8403464

SCHEMBL8403464

NN=Cc1ccc(C(=O)C2C(=O)N(CC(=O)O)Cc3ccccc3N2N)cc1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACE P12821 3/20 0.34
MME P08473 1/20 0.34
ITGB3 P05106 2/20 0.33
ITGA2B P08514 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399657 0.90 KDM4E (0.42) ACEMMEITGB3ITGA2BALDH1A1
SCHEMBL8398839 0.66 PARP1 (0.41) ITGB3ITGA2BALDH1A1MAPTKDM4E
SCHEMBL8402362 0.66 PARP1 (0.40) ITGB3ITGA2BALDH1A1HDAC1HDAC6
SCHEMBL8518894 0.63 BRD4 (0.31)
SCHEMBL199254 0.62 ACE (0.53) ACEMMEKDM4EALOX15TSHR
SCHEMBL30320121 0.62 ACE (0.53) ACEMMEKDM4EALOX15TSHR
SCHEMBL3870683 0.62 ACE (0.53) ACEMMEKDM4EALOX15TSHR
SCHEMBL8897186 0.62 HDAC1 (0.35) ALDH1A1MAPTKDM4EHDAC1HDAC7
SCHEMBL7444173 0.62 ITGB3 (0.72) ITGB3ITGA2B
SCHEMBL8403456 0.61 ITGB3 (0.40) ACEMMEITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693636-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1997-12-02 US claimed
US-5939412-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1999-08-17 US disclosed
US-5693636-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1997-12-02 US disclosed